BMY-21502
| Code | Size | Price |
|---|
| TAR-T30549-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T30549-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T30549-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
BMY-21502 is an identified potential cognitive enhancer, an nootropic agent. In studies it has shown to protect rodents from ECS-induced amnesia in a step-down passive avoidance task.
CAS:
123259-91-6
Formula:
C15H19F3N4O
Molecular Weight:
328.339
Purity:
0.98
SMILES:
FC(F)(F)c1nccc(n1)N1CCC(CN2CCCC2=O)CC1
References
1. Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacol Bull. 1998;34(3):391-7. PubMed PMID: 9803773.
2. Srinivas N, Kaul S. Pharmacokinetics of a nootropic agent, BMY-21502, and its metabolites in beagle dogs. Eur J Drug Metab Pharmacokinet. 1998 Jan-Mar;23(1):61-5. PubMed PMID: 9625274.
3. Shrotriya RC, Cutler NR, Sramek JJ, Veroff AE, Hironaka DY. Efficacy and safety of BMY 21,502 in Alzheimer disease. Ann Pharmacother. 1996 Dec;30(12):1376-80. PubMed PMID: 8968446.
4. Saletu B, Schulz H, Herrmann WM, Anderer P, Shrotriya RC, Vanbrabant E. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Pharmacopsychiatry. 1994 Sep;27(5):189-97. PubMed PMID: 7838889.